News Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Market Closed - Nasdaq Other stock markets 04:00:00 2019-02-22 pm EST			5-day change	1st Jan Change
6.47 ^USD	-0.31%		-.--%	-.--%

Apr. 29	Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 18	Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F	Apr. 29	BU
Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Sinovac - WHO releases 2024-2025 Northern Hemisphere influenza vaccine component recommendations, changes to H3N2 virus	Feb. 26	AQ
Sinovac Amends Shareholder Rights Plan	Feb. 21	BU
Beijing Sinovac Zhongwei Biotechnology Co., Ltd.'s 2024 information disclosure on environmental pollution prevention and control by hazardous wastes	Jan. 26	AQ
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	Jan. 18	BU
Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd.	Jan. 17	CI
Alternative Liquidity Capital Announces Offer to Purchase Common Shares in Sinovac Biotech Ltd.	Jan. 11	AQ
Scientists see risk of lost opportunity for long COVID research in China	Dec. 13	RE
Sinovac - Study shows, Children aged 3-8 years old receive 2 doses of influenza vaccine for better protection	23-10-30	AQ
Sinovac Biotech Ltd - A delegation from the Indonesian Ministry of Health visited Sinovac	23-10-26	AQ
Sinovac - Sharing and co-building China Sinovac has supplied more than 1.2 billion doses of vaccines to 62 'Belt and Road' countries	23-10-23	AQ
Sinovac Biotech : Clinical trials will advance treatment of COVID-19 infection - Form 6-K	23-09-11	PU
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection	23-09-11	BU
Sinovac Biotech Ltd. Reports on the Clinical Trial Progress of Its Anti-Covid-19 Antibody Sa55 Injection	23-09-11	CI
The first study on the protective effect of influenza vaccine for Chinese military personnel shows that Sinovac influenza vaccine has good immunogenicity and safety among military personnel	23-09-06	AQ
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer	23-09-05	BU
Sinovac Holdings Biotechnology Co., Ltd. - Announcement on Industrial and Commercial Change of Beijing Kexing Biological Products Co., Ltd.	23-08-30	AQ
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer	23-08-29	BU
Sinovac Announces Change of Legal Representative of Sinovac Beijing	23-08-28	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Summary

Filters